NCT00865215View on ClinicalTrials.gov

A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Healthy
Interventions
DRUG

Propranolol Hydrochloride Extended Release Capsules 160 mg

A: Experimental Subjects received Actavis formulated products under fasting conditions

DRUG

INDERAL® LA 160 mg Capsules, single dose

B: Active comparator Subjects received Wyeth Pharmaceuticals formulated products under fasting conditions

Trial Locations (1)

58102

PRACS Institute, Ltd., Fargo

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00865215 - A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter